ArticleMetabolic brain disease2025

Nitisinone treatment protect hereditary tyrosinemia type I patients against inflammation, DNA and protein oxidative damage by decreasing succinylacetone levels.

Roberta Barbizan Mascarello et al.PubMed ↗Publisher ↗

No numbers read from the abstract.